The Ahmed ClearPath glaucoma drainage device has been commercially launched in the United States. Available in 350 mm2 and 250 mm2 sizes, the implant includes a flexible plate with a contour that conforms to the curvature of the eye and suture fixation points positioned more anteriorly on the device in comparison to other valveless drainage devices. It is designed to address tube shunt surgery challenges and comes with an optional pre-threaded ripcord and a 23-gauge needle. One feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye. In addition, the suture fixation points are positioned more anteriorly on the device compared to other valveless drainage devices. By making the suture points more visible and accessible, the company said the surgeon may find securing this implant to the eye more convenient. The device or procedures are reserved for mild to moderate glaucoma cases.
The Union Cabinet chaired by Prime Minister Narendra Modi has given approval on the Memorandum of Cooperation (MoC) between India and Japan in the field of healthcare and wellness that was signed in October 2018.
BLK Super Speciality Hospital achieved another milestone by crossing 1,000 bone marrow transplants. BLK Centre for BMT has emerged as Asia’s largest BMT unit...
Species-specific Liver-Chip identifies distinct drug toxicities in human, rat, and dog models; Could improve success rate of drug candidates in clinical trials.